{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1801"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Employee Retirement Income Security Act of\n\t\t  1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to\n\t\t  require group and individual health insurance coverage and group health plans\n\t\t  to provide for coverage of oral anticancer drugs on terms no less favorable\n\t\t  than the coverage provided for anticancer medications administered by a health\n\t\t  care provider."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130426", "#text": "April 26, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committees on\n\t\t\t ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, {"#tail": " and\n\t\t\t ", "@committee-id": "HWM00", "#text": "Ways and Means"}, {"#tail": ", for a period to be subsequently determined by the\n\t\t\t Speaker, in each case for consideration of such provisions as fall within the\n\t\t\t jurisdiction of the committee concerned", "@committee-id": "HED00", "#text": "Education and the\n\t\t\t Workforce"}], "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Higgins", "@name-id": "H001038"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Ms. Moore", "@name-id": "M001160"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Pingree of Maine", "@name-id": "P000597"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Cicilline", "@name-id": "C001084"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Capps", "@name-id": "C001036"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Grijalva", "@name-id": "G000551"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Wilson of Florida", "@name-id": "W000808"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Hastings of Florida", "@name-id": "H000324"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. King of New York", "@name-id": "K000210"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rangel", "@name-id": "R000053"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Larsen of Washington", "@name-id": "L000560"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. McGovern", "@name-id": "M000312"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Peters of California", "@name-id": "P000608"}, {"#tail": ", ", "#text": "Mr. Wolf", "@name-id": "W000672"}, {"#tail": ", and ", "#text": "Mr. Moran", "@name-id": "M000933"}, {"#tail": ") introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mr.\n\t\t\t Farr", "@name-id": "F000030"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H0A565D39F13341AB800F1A103ACA1B2D", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Cancer Drug Coverage Parity Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H2E32C286449042428E8183052E6BA6E6"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Parity in\n\t\t\t coverage for oral anticancer drugs"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Employee\n\t\t\t Retirement Income Security Act of 1974 amendments"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is\n\t\t\t amended by adding at the end the following new section:", "@entity-type": "act", "#text": "Subpart B of part 7 of\n\t\t\t subtitle B of title I of the Employee Retirement Income Security Act of 1974", "@value": "Employee Retirement Income Security Act of 1974/t:I/st:B/pt:7/spt:B"}, "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "716."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Parity in\n\t\t\t\tcoverage for oral anticancer drugs"}, "subsection": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a group health plan, and a health insurance issuer providing health\n\t\t\t\tinsurance coverage in connection with a group health plan, that provides\n\t\t\t\tbenefits with respect to anticancer medications administered by a health care\n\t\t\t\tprovider shall provide for no less favorable coverage for prescribed,\n\t\t\t\tpatient-administered anticancer medications that are used to kill, slow, or\n\t\t\t\tprevent the growth of cancerous cells and that have been approved by the Food\n\t\t\t\tand Drug Administration.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:b", "@proposed": "true"}, "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "HC0A848A4DAEF4FC0B1C8CF99DDFBFBDD"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall only apply to an anticancer medication that is prescribed based on a\n\t\t\t\tfinding by the treating physician that the medication\u2014", "@entity-type": "act", "#text": "Subsection\n\t\t\t\t(a)", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:a", "@proposed": "true"}, "#text": "\n                  "}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is medically\n\t\t\t\tnecessary for the purpose of killing, slowing, or preventing the growth of\n\t\t\t\tcancerous cells; or"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "H3256B041E04B4034A12EAE8BEEB1528E", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is clinically\n\t\t\t\tappropriate in terms of type, frequency, extent site, and duration."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "#text": "\n                  ", "@id": "H753CBE56031F4EF08B23170079FF4261", "@commented": "no"}], "#text": "\n                ", "@id": "HF2DE46DF47EE404688C415988804691A", "@commented": "no"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Application of\n\t\t\t\tcost-Sharing and restrictions"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may be subject to annual deductibles and coinsurance or copayments so long\n\t\t\t\tas such deductibles, coinsurance, and copayments do not exceed the deductibles,\n\t\t\t\tcoinsurance, and copayments that are applicable to anticancer medications\n\t\t\t\tadministered by a health care provider under the plan or coverage for the same\n\t\t\t\tpurpose.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:a", "@proposed": "true"}, "#text": "The coverage of anticancer medication under "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "H1D93C2C39F8B43709857CD3CDDCC4AF3"}, {"#tail": "\n              ", "@id": "HB41761FB504F4EFAAD525A264A4FE686", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Restriction"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:a", "@proposed": "true"}, "#text": "A group health plan or health insurance\n\t\t\t\tissuer may not, in order to comply with the requirement of ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "impose an increase\n\t\t\t\tin out-of-pocket costs with respect to anticancer medications;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "#text": "\n                    ", "@id": "H550B46F01E4546B1BD7BAE0D1BEF7607", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "reclassify benefits with respect to\n\t\t\t\tanticancer medications; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "#text": "\n                    ", "@id": "HF8B36D8D02B246D9841C18EEB43BB602", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "apply more\n\t\t\t\trestrictive limitations on prescribed orally-administered anticancer\n\t\t\t\tmedications or intravenously administered or injected anticancer\n\t\t\t\tmedications."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "H98F9BEB3FCFF41FA9D69C02BEF15F731", "#text": "\n                    "}], "@commented": "no"}], "#text": "\n                ", "@id": "HB2B28A98B069422AA892CCF19838B447"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (b)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:b"}, {"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "(c)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:c"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(d)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:d"}, {"#tail": " shall apply with respect to the coverage\n\t\t\t\trequired by ", "@entity-type": "act", "#text": "(e)(2) of section 713", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2"}, {"#tail": " in the same manner as they apply with respect to the\n\t\t\t\tcoverage required under such section, except that January 1, 2014, shall be\n\t\t\t\tsubstituted for the date referred to in ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)(3) of such\n\t\t\t\tsection", "@value": "Employee Retirement Income Security Act of 1974/s:716/ss:b/p:3", "@proposed": "true"}], "#text": "The provisions of "}, "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n                ", "#text": "Application of\n\t\t\t\tnotice, prohibitions, etc"}, "#text": "\n                ", "@id": "H2668E4BE3583479B93BDCBDAC2EFE481"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing\n\t\t\t\tin this section shall be construed\u2014"}, "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n                ", "#text": "Construction"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to require the use of orally-administered\n\t\t\t\tanticancer medications as a replacement for other anticancer medications;\n\t\t\t\tor", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "HF11967F9A5CF48348DEAD4635DA6E1C7", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to prohibit a\n\t\t\t\tgroup health plan or health insurance issuer from requiring prior authorization\n\t\t\t\tor imposing other appropriate utilization controls in approving coverage for\n\t\t\t\tany\n\t\t\t\tchemotherapy."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "HED6CC730403D4E819288BA3F36556064", "#text": "\n                  "}], "#text": "\n                ", "@id": "H96383291B5BD40CDA7CB3C021A9FA45E"}], "#text": "\n              ", "@id": "H5D9FD111F0C04B98A18FA0F410FF63CE"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H3637BE9A718B4686BCECDA1E41E4EFA9"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "HB1AD2E8CD0F8496491234A021D4655FC", "@commented": "no"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting\n\t\t\t ", "#text": "section 711"}, {"#tail": ".", "#text": "sections 711 and 716"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 731(c) of such Act", "@value": "Employee Retirement Income Security Act of 1974/s:731/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "29 U.S.C.\n\t\t\t 1191(c)", "@value": "usc/29/1191/c"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "HE064ADC930A148EAB982D245F022F743"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting\n\t\t\t ", "#text": "section 711"}, {"#tail": ".", "#text": "sections 711 and 716"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 732(a) of such Act", "@value": "Employee Retirement Income Security Act of 1974/s:732/ss:a"}, {"#tail": ")", "@entity-type": "uscode", "#text": "29 U.S.C.\n\t\t\t 1191a(a)", "@value": "usc/29/1191a/a"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H5AF2617C44CA4AC4854AF2E53C00FB16"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is amended by inserting after the item relating to ", "@entity-type": "act", "#text": "section 1 of\n\t\t\t such Act", "@value": "Employee Retirement Income Security Act of 1974/s:1"}, {"#tail": " the\n\t\t\t following new items:", "@entity-type": "act", "#text": "section 714", "@value": "Employee Retirement Income Security Act of 1974/s:714"}], "#text": "The table of contents in "}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "toc": {"#tail": "\n\t\t\t\t\t\t", "toc-entry": [{"#tail": "\n\t\t\t\t\t\t\t", "#text": "Sec. 715. Additional market\n\t\t\t\treforms.", "@level": "section"}, {"#tail": "\n\t\t\t\t\t\t", "#text": "Sec. 716. Parity in coverage for oral\n\t\t\t\tanticancer\n\t\t\t\tdrugs.", "@level": "section"}], "#text": "\n\t\t\t\t\t\t\t", "@regeneration": "no-regeneration"}, "#text": "\n\t\t\t\t\t\t", "@id": "H88CEF95CDED14D5E99C4A3DEE6672D16"}, "#text": "\n          ", "@id": "H065A174D715348A18F6F9EC21E860461"}], "#text": "\n        ", "@id": "H996849631CAE469088A8AEFC37FEA381"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Public health\n\t\t\t service act amendments"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Title XXVII of the Public Health Service\n\t\t\t Act", "@value": "Public Health Service Act/t:XXVII"}, "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ", as\n\t\t\t redesignated by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 2728", "@value": "Public Health Service Act/s:2728"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/42/300gg-28", "#text": "42 U.S.C. 300gg\u201328", "@legal-doc": "usc"}}, {"#tail": ", the following new section:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1001(2) of the Patient Protection and Affordable Care\n\t\t\t Act", "@value": "Patient Protection and Affordable Care Act/s:1001/p:2"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}], "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "2729."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Parity in\n\t\t\t\tcoverage for oral anticancer drugs"}, "subsection": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a group health plan, and a health insurance issuer offering health\n\t\t\t\tinsurance coverage, that provides benefits with respect to anticancer\n\t\t\t\tmedications administered by a health care provider shall provide for no less\n\t\t\t\tfavorable coverage for prescribed, patient-administered anticancer medications\n\t\t\t\tthat are used to kill, slow, or prevent the growth of cancerous cells and that\n\t\t\t\thave been approved by the ", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Public Health Service Act/s:2729/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "H16EEF67B9D4C459BA71515ACCD798586"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall only apply to an anticancer medication that is prescribed based on a\n\t\t\t\tfinding by the treating physician that the medication\u2014", "@entity-type": "act", "#text": "Subsection\n\t\t\t\t(a)", "@value": "Public Health Service Act/s:2729/ss:a", "@proposed": "true"}, "#text": "\n                  "}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is medically\n\t\t\t\tnecessary for the purpose of killing, slowing, or preventing the growth of\n\t\t\t\tcancerous cells; or"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "H6EF99367822940AAB80990AB2D5C1245", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is clinically\n\t\t\t\tappropriate in terms of type, frequency, extent site, and duration."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "#text": "\n                  ", "@id": "HA2F853B70B724150829F8DAF2A86EAA0", "@commented": "no"}], "#text": "\n                ", "@id": "H9AF2164BC45446D2ADBEBA9FF4FE7137", "@commented": "no"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Application of\n\t\t\t\tcost-Sharing and restrictions"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may be subject to annual deductibles\n\t\t\t\tand coinsurance or copayments so long as such deductibles, coinsurance, and\n\t\t\t\tcopayments do not exceed the deductibles, coinsurance, and copayments that are\n\t\t\t\tapplicable to anticancer medications administered by a health care provider\n\t\t\t\tunder the plan or coverage for the same purpose.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Public Health Service Act/s:2729/ss:a", "@proposed": "true"}, "#text": "The coverage of\n\t\t\t\tanticancer medication under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "HD1AD4F6F5A7241A0818018F679E928C1"}, {"#tail": "\n              ", "@id": "HE8A7FF98FDFD42C3B5EC44E38EE6A21B", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Restriction"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Public Health Service Act/s:2729/ss:a", "@proposed": "true"}, "#text": "A group health plan or health insurance\n\t\t\t\tissuer may not, in order to comply with the requirement of ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "impose an increase\n\t\t\t\tin out-of-pocket costs with respect to anticancer medications;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "#text": "\n                    ", "@id": "HB78BD5A6B3F24C8F9E6A965901950436", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "reclassify benefits with respect to\n\t\t\t\tanticancer medications; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "#text": "\n                    ", "@id": "H1BBF97F9C4364458B2F1FEE9078E3947", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "apply more\n\t\t\t\trestrictive limitations on prescribed orally-administered anticancer\n\t\t\t\tmedications or intravenously administered or injected anticancer\n\t\t\t\tmedications."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "H5C70F80CB9EE4870AFCA37CEB4AFB1CB", "#text": "\n                    "}], "@commented": "no"}], "#text": "\n                ", "@id": "HF8249A070B814093B102AF345DDF0DEB"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (b)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:b"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:c"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(d)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:d"}, {"#tail": " shall apply with respect to\n\t\t\t\tthe coverage required by ", "@entity-type": "act", "#text": "(e)(2) of section 713 of the\n\t\t\t\tEmployee Retirement and Income Security Act of 1974", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2"}, {"#tail": " in the same manner as they apply with\n\t\t\t\trespect to the coverage required under such section, except that January 1,\n\t\t\t\t2014, shall be substituted for the date referred to in ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Public Health Service Act/s:2729/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)(3) of\n\t\t\t\tsuch section", "@value": "Public Health Service Act/s:2729/ss:b/p:3", "@proposed": "true"}], "#text": "The\n\t\t\t\tprovisions of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n                ", "#text": "Application of\n\t\t\t\tnotice, prohibitions, etc"}, "#text": "\n                ", "@id": "HCE6B810A25FA4FAAA3AA1C3BA5F7C637"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing\n\t\t\t\tin this section shall be construed\u2014"}, "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n                ", "#text": "Construction"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to require the use of orally-administered\n\t\t\t\tanticancer medications as a replacement for other anticancer medications;\n\t\t\t\tor", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "H1ED71A87E7254C4297C9DD9818C14285", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to prohibit a\n\t\t\t\tgroup health plan or health insurance issuer from requiring prior authorization\n\t\t\t\tor imposing other appropriate utilization controls in approving coverage for\n\t\t\t\tany\n\t\t\t\tchemotherapy."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H61ABE0EA1C42486DB160827D3D6C0BFF", "#text": "\n                  "}], "#text": "\n                ", "@id": "H7F9F404C5CDC4E488A22B25BA4EED4EA"}], "#text": "\n              ", "@id": "H06FE21AAA32F42D4B71ED7BF5E023065"}, "#text": "\n\t\t\t\t\t\t", "@id": "HF61B547E6A20469997CA5BAE989BC14F"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "H64018BDD32784179AEEBCCB4B2AA9BF1", "@commented": "no"}, {"@indent": "up1", "#tail": "\n        ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "public-law", "#text": "section 1001(4)", "@value": "public-law/111/148/s:1001/p:4"}, {"#tail": " (relating to conforming amendments) of ", "@entity-type": "public-law", "#text": "subsection (c)(14)\n\t\t\t of the section 1563", "@value": "public-law/111/148/s:1563/ss:c/p:14"}], "#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting\n\t\t\t ", "#text": "section 2704"}, {"#tail": ".", "#text": "sections 2725 and 2729"}], "external-xref": {"#tail": ",\n\t\t\t is amended by striking ", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as redesignated by ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 2724(c) of such Act", "@value": "Public Health Service Act/s:2724/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 300gg\u201323(c)", "@value": "usc/42/300gg\u201323/c"}], "@entity-type": "law-citation", "#text": "\n              "}, "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "H7B6A778707F54025AA4C2BC893EACF89"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and\n\t\t\t inserting ", "#text": "section 2751"}, {"#tail": ".", "#text": "sections 2751 and 2729"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 2762(b)(2) of such Act", "@value": "Public Health Service Act/s:2762/ss:b/p:2"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 300gg\u201362(b)(2)", "@value": "usc/42/300gg\u201362/b/2"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H008FEAAFC6F2418BBE85E4884A0890CD"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as inserted by ", "@entity-type": "act", "#text": "section 2729 of\n\t\t\t the Public Health Service Act", "@value": "Public Health Service Act/s:2729", "@proposed": "true"}, {"#tail": ", to individual\n\t\t\t health insurance coverage before 2014, the provisions of such section shall be\n\t\t\t treated as also included under ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Cancer Drug Coverage Parity Act of 2013/s:2/ss:b/p:1", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "part B of title XXVII of the Public Health\n\t\t\t Service Act", "@value": "Public Health Service Act/t:XXVII/pt:B"}], "#text": "For purposes of applying ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "#text": "\n          ", "@id": "H04AF981DFBDE4502B4E1554F4B71754D"}], "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "H3013A0D0CFB24B7DB9F610B5815626FF"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Internal revenue\n\t\t\t code amendments"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as amended by ", "@entity-type": "act", "#text": "Subchapter B of chapter 100 of the Internal Revenue Code\n\t\t\t of 1986", "@value": "Internal Revenue Code of 1986/ch:100/sch:B"}, {"#tail": " (relating to\n\t\t\t conforming amendments) of ", "@entity-type": "public-law", "#text": "subsection (f) of the section 1563", "@value": "public-law/111/148/s:1563/ss:f"}], "#text": "\n            ", "external-xref": {"#tail": ", is amended by adding at the end\n\t\t\t the following new section:", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "9816."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Parity in\n\t\t\t\tcoverage for oral anticancer drugs"}, "subsection": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a group health plan that provides benefits with respect to anticancer\n\t\t\t\tmedications administered by a health care provider shall provide for no less\n\t\t\t\tfavorable coverage for prescribed, patient-administered anticancer medications\n\t\t\t\tthat are used to kill, slow, or prevent the growth of cancerous cells and that\n\t\t\t\thave been approved by the ", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Internal Revenue Code of 1986/s:9816/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "H6728323FDC6C4077A568EDF060949BCE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall only apply to an anticancer medication that is prescribed based on a\n\t\t\t\tfinding by the treating physician that the medication\u2014", "@entity-type": "act", "#text": "Subsection\n\t\t\t\t(a)", "@value": "Internal Revenue Code of 1986/s:9816/ss:a", "@proposed": "true"}, "#text": "\n                  "}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is medically\n\t\t\t\tnecessary for the purpose of killing, slowing, or preventing the growth of\n\t\t\t\tcancerous cells; or"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "HE2C7F240407D4B72964743DCFEB719DE", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is clinically\n\t\t\t\tappropriate in terms of type, frequency, extent site, and duration."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "#text": "\n                  ", "@id": "H7A8CF8433FB041E5B6F99058760B4365", "@commented": "no"}], "#text": "\n                ", "@id": "H3247223A703747F08D8FB2669A4D3D0C", "@commented": "no"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Application of\n\t\t\t\tcost-Sharing and restrictions"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may be subject to annual deductibles\n\t\t\t\tand coinsurance or copayments so long as such deductibles, coinsurance, and\n\t\t\t\tcopayments do not exceed the deductibles, coinsurance, and copayments that are\n\t\t\t\tapplicable to anticancer medications administered by a health care provider\n\t\t\t\tunder the plan for the same purpose.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Internal Revenue Code of 1986/s:9816/ss:a", "@proposed": "true"}, "#text": "The coverage of\n\t\t\t\tanticancer medication under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "H3DCEEF1704C640838B76B0A848812CDE"}, {"#tail": "\n              ", "@id": "H87278E0FD73C4E51A61B38EB9804F60A", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Restriction"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Internal Revenue Code of 1986/s:9816/ss:a", "@proposed": "true"}, "#text": "A group health plan may not, in order to\n\t\t\t\tcomply with the requirement of ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "impose an increase\n\t\t\t\tin out-of-pocket costs with respect to anticancer medications;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "#text": "\n                    ", "@id": "H895BB0C7640E460C861C686D0BF48300", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "reclassify benefits with respect to\n\t\t\t\tanticancer medications; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "#text": "\n                    ", "@id": "HA81F1C52C36840D9A2617EC14CFA81F1", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "apply more\n\t\t\t\trestrictive limitations on prescribed orally-administered anticancer\n\t\t\t\tmedications or intravenously administered or injected anticancer\n\t\t\t\tmedications."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "H634F7285C7374FC6970B73D08876E9B3", "#text": "\n                    "}], "@commented": "no"}], "#text": "\n                ", "@id": "H62C8A5B61E6840B298F836C04F2BF716"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (b)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:b"}, {"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "(c)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:c"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(d)", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:d"}, {"#tail": " shall apply with respect to the coverage required by ", "@entity-type": "act", "#text": "(e)(2) of section 713 of the Employee Retirement and Income Security\n\t\t\t\tAct of 1974", "@value": "Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2"}, {"#tail": "\n\t\t\t\tin the same manner as they apply with respect to the coverage required under\n\t\t\t\tsuch section, except that January 1, 2014, shall be substituted for the date\n\t\t\t\treferred to in ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Internal Revenue Code of 1986/s:9816/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)(3) of such section", "@value": "Internal Revenue Code of 1986/s:9816/ss:b/p:3", "@proposed": "true"}], "#text": "The provisions of "}, "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n                ", "#text": "Application of\n\t\t\t\tnotice, prohibitions, etc"}, "#text": "\n                ", "@id": "H4E2532B6E1CC44A1935FADFA0B9CF762"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing\n\t\t\t\tin this section shall be construed\u2014"}, "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n                ", "#text": "Construction"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to require the use of orally-administered\n\t\t\t\tanticancer medications as a replacement for other anticancer medications;\n\t\t\t\tor", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "H79E1961AE5384E5C9FD145EB9230ED57", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to prohibit a\n\t\t\t\tgroup health plan or health insurance issuer from requiring prior authorization\n\t\t\t\tor imposing other appropriate utilization controls in approving coverage for\n\t\t\t\tany\n\t\t\t\tchemotherapy."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H80E99E36134448AF8267F34AA99551A1", "#text": "\n                  "}], "#text": "\n                ", "@id": "H2682627B6B744686845C2E79E5EEEB9F"}], "#text": "\n              ", "@id": "H5FE28C5F44B64BA999F8DCD872A5911D"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H9AF9DA072509449992A4ED28BD46DF3C"}, "#text": "\n          ", "@id": "HF940F8A31E3D4C1C861CC593B9B2418C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "The table of sections for such subchapter is amended by\n\t\t\t adding at the end the following new items:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Clerical\n\t\t\t amendment"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "toc": {"#tail": "\n\t\t\t\t\t\t", "toc-entry": [{"#tail": "\n\t\t\t\t\t\t\t", "#text": "Sec.\u20029815. Additional market\n\t\t\t\treforms.", "@level": "section"}, {"#tail": "\n\t\t\t\t\t\t", "#text": "Sec. 9816. Parity in coverage for oral\n\t\t\t\tanticancer\n\t\t\t\tdrugs.", "@level": "section"}], "#text": "\n\t\t\t\t\t\t\t", "@regeneration": "no-regeneration"}, "#text": "\n\t\t\t\t\t\t", "@id": "H66DE41722CDD4E16962FD9B6832D4CDC"}, "#text": "\n          ", "@id": "HF2D9F4653C1E4C309C93BAD3DCA04A1E"}], "#text": "\n        ", "@id": "H06ABD7D7DF4643B7A960113EAF9D5293"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is amended\n\t\t\t by adding at the end the following new clause:", "@entity-type": "public-law", "#text": "section 2301(a) of ", "external-xref": {"#tail": "\n          ", "@parsable-cite": "pl/111/152", "#text": "Public Law 111\u2013152", "@legal-doc": "public-law"}, "@value": "public-law/111/152/s:2301/ss:a"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as added by ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1251(a)(4)(A) of the Patient\n\t\t\t Protection and Affordable Care Act", "@value": "Patient Protection and Affordable Care Act/s:1251/ss:a/p:4/sp:A"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 18011(a)(4)(A)", "@value": "usc/42/18011/a/4/A"}], "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": "; ", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Clarifying\n\t\t\t amendment regarding application to grandfathered plans"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "clause": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "Section 2729", "@value": "Public Health Service Act/s:2729", "@proposed": "true"}, {"@proposed": "true", "#tail": ".", "@entity-type": "act", "@value": "Cancer Drug Coverage Parity Act of 2013/s:2/ss:b", "short-title": {"#tail": "\n              ", "#text": "Cancer Drug Coverage Parity Act of\n\t\t\t\t2013"}, "#text": "section 2(b) of\n\t\t\t\tthe "}], "#text": "\n              ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(v)"}, "@id": "H71F75B1DC4864FA090D53B14A1222939", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H33D1B4EA97B84E789A8279763AE9AA86"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "H933B683720F741AC92B2F96FA318EDE9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The amendments made by\n\t\t\t this section shall apply with respect to group health plans for plan years\n\t\t\t beginning on or after January 1, 2014, and with respect to health insurance\n\t\t\t coverage offered, sold, issued, renewed, in effect, or operated in the\n\t\t\t individual market on or after such date.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "H116AAD2BD27341F0BB3CA7A4B0E1E460"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "Not later than 2 years after the date of\n\t\t\t the enactment of this Act\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n        ", "#text": "Study"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall complete a study that assesses how closing\n\t\t\t the Medicare part D donut hole under the amendments made by ", "@entity-type": "federal-body", "#text": "Medicare\n\t\t\t Payment Advisory Commission", "@entity-id": "4835"}, "#text": "the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ", as amended by\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 3301 of the\n\t\t\t Patient Protection and Affordable Care Act", "@value": "Patient Protection and Affordable Care Act/s:3301"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}, {"#tail": ", affects Medicare coverage for orally administered\n\t\t\t anticancer medications, with a particular focus on cost and accessibility;\n\t\t\t and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "section 1101 of the Health Care and Education Reconciliation Act of 2010", "@value": "Health Care and Education Reconciliation Act of 2010/s:1101"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "pl/111/152", "#text": "Public Law 111\u2013152", "@legal-doc": "public-law"}}]}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HB465D2F51B3844EABD079D2C71FF4D55", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " on the results of such study.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "submit a report to\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H0BEA5B219AF441ED8AFC47882651CD3C", "#text": "\n          "}], "#text": "\n        ", "@id": "HD79329F22A6F487F916E2AE19B19B5E4"}], "#text": "\n      ", "@id": "HE1703CE9667A40B9915D5B24158322DD"}], "#text": "\n\t\t", "@id": "H5C3547A9E221483FA7912C2603D964B0"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-04-26"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1801 IH: Cancer Drug Coverage Parity Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}